Eucrates Biomedical Acquisition (EUCR) stock forecast for 2022 – 2027

Are you interested in Eucrates Biomedical Acquisition Corp. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EUCR stock price in 2022-2027. Is EUCR a good long term stock? When should I take profit in Eucrates Biomedical Acquisition stock? Buy or sell stock? Will EUCR stock price go up? What are analysts’ forecasts for EUCR stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EUCR stock returns are also predicted based on historical data.

According to our research, EUCR stock is a bad long-term investment. EUCR share price has been in a bear cycle for the past year. Eucrates Biomedical Acquisition Corp. stock trend is negative.

Eucrates Biomedical Acquisition company info

Industry Shell Companies
Address 250 West 55th Street, New York, NY, 10019, United States
Website

Forecasting

52 Week High: 10.0717 USD
52 Week Low: 2.973 USD
1 Year Forecast: 2.973 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 131.56M
52 Week Change: -0.505%
52 Week High: 10.88 USD
52 Week Low: 9.59 USD
Beta: 0
50 Day Moving Average: 9.8
90 Day Moving Average: 9.809
200 Day Moving Average: 9.77
Resistance Level: 9.783
Pivot Point: 9.58146
Support Level: 9.768
Enterprise Value: 131,424,024
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0.00%
Shares Outstanding: 13,459,100
EBITDA: 0
Held Percent Institutions: 38.05%
PEG Ratio (5Y): 0
Trailing EPS: 0

Eucrates Biomedical Acquisition stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Eucrates Biomedical Acquisition Stock Forecast for 2022

March 2022 8.91 8.08 -9.32%
April 2022 8.08 7.84 -2.97%
May 2022 8.08 7.14 -11.63%
June 2022 7.14 5.94 -16.81%
July 2022 6.86 6 -12.54%
August 2022 5.94 4.95 -16.67%
September 2022 4.95 5 1.01%
October 2022 4.9 4 -18.37%
November 2022 4.08 4.04 -0.98%
December 2022 3.92 3.06 -21.94%

Eucrates Biomedical Acquisition Stock Forecast for 2023

January 2023 3.06 2.02 -33.99%
February 2023 2.02 2.02 0%
March 2023 2.02 0.99 -50.99%
April 2023 1.01 1.02 0.99%
May 2023 1 0 -100%
June 2023 0 0 -100%
July 2023 0 0 -100%
August 2023 0 0 -100%
September 2023 0 0 -100%
October 2023 0 0 -100%
November 2023 0 0 -100%
December 2023 0 0 -100%

Eucrates Biomedical Acquisition Stock Forecast for 2024

January 2024 0 0 -100%
February 2024 0 0 -100%
March 2024 0 0 -100%
April 2024 0 0 -100%
May 2024 0 0 -100%
June 2024 0 0 -100%
July 2024 0 0 -100%
August 2024 0 0 -100%
September 2024 0 0 -100%
October 2024 0 0 -100%